These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6574962)

  • 21. Natural killer activity of pediatric patients with acute lymphoblastic leukemia in remission.
    Inada M; Okawa H; Suzuki M; Yata J
    Jpn J Clin Oncol; 1984 Sep; 14(3):335-45. PubMed ID: 6592376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The role of costimulatory molecules in immune responses in acute leukemia].
    Cielińska S; Urbaniak-Kujda D; Kapelko-Słowik K; Kuliczkowski K
    Pol Arch Med Wewn; 2001 May; 105(5):417-21. PubMed ID: 11865595
    [No Abstract]   [Full Text] [Related]  

  • 23. [Human nonspecific killer cells].
    Thränhardt H; Zintl F; Milleck J; Jantscheff P; Hermann J; Fuchs D; Voigt P; Metz O; Löbe LP; Mohr F; Plenert W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(3):390-407. PubMed ID: 6182059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural killer-mediated lysis of normal and malignant target cells, and its regulation by monocytes.
    Oshimi K; Oshimi Y; Satake M; Mizoguchi H
    J Exp Med; 1985 Aug; 162(2):472-86. PubMed ID: 3874925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extravascular natural cytotoxicity in man: Anti-K562 activity of lymph-node and tumour-infiltrating lymphocytes.
    Moore M; Vose BM
    Int J Cancer; 1981 Mar; 27(3):265-72. PubMed ID: 6169658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunomodulatory Drugs Exert Anti-Leukemia Effects in Acute Myeloid Leukemia by Direct and Immunostimulatory Activities.
    Le Roy A; Prébet T; Castellano R; Goubard A; Riccardi F; Fauriat C; Granjeaud S; Benyamine A; Castanier C; Orlanducci F; Ben Amara A; Pont F; Fournié JJ; Collette Y; Mege JL; Vey N; Olive D
    Front Immunol; 2018; 9():977. PubMed ID: 29780393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strong natural killer (NK) cell activity in bone marrow of myeloma patients: accelerated maturation of bone marrow NK cells and their interaction with other bone marrow cells.
    Uchida A; Yagita M; Sugiyama H; Hoshino T; Moore M
    Int J Cancer; 1984 Sep; 34(3):375-81. PubMed ID: 6592156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL.
    Boeck CL; Amberger DC; Doraneh-Gard F; Sutanto W; Guenther T; Schmohl J; Schuster F; Salih H; Babor F; Borkhardt A; Schmetzer H
    J Immunother; 2017; 40(6):224-248. PubMed ID: 28557814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Augmentation of immune responses of pelvic lymph node lymphocytes in patients with cervical cancer by sizofiran.
    Shimizu Y; Chen JT; Hirai Y; Nakayama K; Hamada T; Fujimoto I; Hasumi K; Masubuchi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Dec; 41(12):2013-4. PubMed ID: 2531784
    [No Abstract]   [Full Text] [Related]  

  • 30. Human natural cytotoxicity in the blood and lymphoid organs of healthy donors and patients with malignant disease.
    Eremin O; Ashby J; Stephens JP
    Int J Cancer; 1978 Jan; 21(1):35-41. PubMed ID: 342425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural killer cells in acute myeloid leukemia patients: from phenotype to transcriptomic analysis.
    Venton G; Labiad Y; Colle J; Fino A; Afridi S; Torres M; Monteuil S; Loriod B; Fernandez-Nunez N; Farnault L; Suchon P; Mattei JC; Rihet P; Bergon A; Nguyen C; Baier C; Costello R
    Immunol Res; 2016 Dec; 64(5-6):1225-1236. PubMed ID: 27481509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-2 induces cytotoxic activity in lymphocytes from regional axillary nodes of breast cancer patients.
    Bonilla F; Alvarez-Mon M; Merino F; de la Hera A; Alés JE; España P; Durántez A
    Cancer; 1988 Feb; 61(4):629-34. PubMed ID: 3257405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extremely high levels of natural killer cells in angioimmunoblastic lymphadenopathy.
    Ligler FS; Patel M; Strayer D; Brodsky I; Bonner H; Linna TJ
    J Clin Immunol; 1983 Oct; 3(4):375-81. PubMed ID: 6361048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Appearance of killer (K) cells in the mesenteric lymph nodes in Crohn's disease.
    Britton S; Eklund AE; Bird AG
    Gastroenterology; 1978 Aug; 75(2):218-20. PubMed ID: 669207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-2 corrects defective NK activity of patients with leukemia.
    Lotzová E; Savary CA
    Comp Immunol Microbiol Infect Dis; 1986; 9(2-3):169-75. PubMed ID: 3491726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural antitumour cytotoxicity of mouse lymph node cells; characterization and specificity studies.
    Hassan ZM; Rees RC
    Eur J Cancer (1965); 1980 Sep; 16(9):1263-70. PubMed ID: 7227450
    [No Abstract]   [Full Text] [Related]  

  • 37. Natural killer cell (NK) subsets and NK-like T-cell populations in acute myeloid leukemias and myelodysplastic syndromes.
    Aggarwal N; Swerdlow SH; TenEyck SP; Boyiadzis M; Felgar RE
    Cytometry B Clin Cytom; 2016 Jul; 90(4):349-57. PubMed ID: 26648320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural killer (NK) activity of normal human peripheral blood lymphocytes against erythroleukemic cell line K 562.
    Tanaka Y
    Hiroshima J Med Sci; 1981 Jun; 30(2):115-26. PubMed ID: 6946049
    [No Abstract]   [Full Text] [Related]  

  • 39. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia.
    Suzuki R; Nakamura S
    Leuk Res; 1999 Jul; 23(7):615-24. PubMed ID: 10400182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of CD158 and NKG2A Inhibitory Receptors and Underexpression of NKG2D and NKp46 Activating Receptors on NK Cells in Acute Myeloid Leukemia.
    Sandoval-Borrego D; Moreno-Lafont MC; Vazquez-Sanchez EA; Gutierrez-Hoya A; López-Santiago R; Montiel-Cervantes LA; Ramírez-Saldaña M; Vela-Ojeda J
    Arch Med Res; 2016 Jan; 47(1):55-64. PubMed ID: 26876298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.